Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Geron Corporation
 | This article needs to be updated. (September 2021) |
 | |
| Company type | Public |
|---|---|
| Nasdaq: GERN Russell 2000 Component | |
| Industry | Biotechnology |
| Founded | 1990 |
| Headquarters | Foster City, California, U.S. |
Key people | John Scarlett (President, CEO) Olivia Bloom (CFO) |
| Products | Cancer drugs (currently in human trials) |
| Revenue |  USD 1.39 million (2021) |
 USD-$116 million (2021) | |
| Total assets | USD$226 million (2021) |
| Total equity | USD$126 million (2021) |
Number of employees | 82 |
| Website | www |
| Footnotes / references [1] | |
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
- ^ "Geron 2021 10K Annual Report". U.S. Securities and Exchange Commission. Retrieved 9 May 2022.
Previous Page Next Page
